Sarepta Therapeutics got the go-ahead to file for approval of its experimental drug for Duchenne muscular dystrophy.» Read More
Some medical groups now want doctors to consider both the effectiveness and costs of treatment options.
Enrollment in private Obamacare plans topped 8 million, the president announced Thursday.
California enrolled about 3.3 million in either private Obamacare plans or the state's version of Medicaid, officials announced Thursday.
This week the headline appeared to have some tough news for RNA companies, but Alnylam remains undeterred about the potential of its treatments.
According to a Gallup poll, Obamacare helped 10 million Americans to get new health insurance, making the percentage of insured people plummet.
UnitedHealth Group's earnings outlook will be limited, according to Citi analyst Carl McDonald, who downgraded shares of the nation's largest insurer to "neutral" from "buy."
New research shows insurers' efforts to entice healthy eating with coupons are paying off. But are the foods as healthy as the savings?
The effects of Obamacare will be difficult to measure as the Census Bureau is changing its annual survey. NYT reports.
CEO John Chen talks about BlackBerry's new health-care tech deal and how it plays into one of the company's core strategies.
Johnson & Johnson turned in a solid first quarter Tuesday, topping analysts' profit and revenue estimates and increasing its 2014 earnings forecast by 5 cents a share.
Americans used more health services and spent more on prescription drugs in 2013, reversing a recent trend.
A man may have been allowed to use an electronic cigarette on a flights from Calgary to Toronto.
The London Fire Brigade has warned on the risks of e-cigarettes after one device apparently exploded and caused a fire.
US budget deficits over the next decade will be $286 billion less than previously estimated, the Congressional Budget Office said on Monday.
Shares of Biogen Idec, Celgene, Gilead Sciences, and Lexicon Pharmaceuticals recovered from last week's selloff.
GlaxoSmithKline is facing a criminal investigation in Poland for allegedly bribing doctors to promote its asthma drug Seretide, BBC Panorama reported on Sunday.
Outgoing health secretary Kathleen Sebelius's goodbye at the White House featured one last flub—a page that vanished from her prepared remarks.
A massive dump of data about Medicare reimbursements to physicians raised eyebrows for the millions paid to some doctors, but the data aren't perfect.
Her resignation comes just days after the initial enrollment period for Obamacare ended.
Releasing data about Medicare reimbursements to doctors could have led to cost savings in the past, but legal rulings kept it hidden for 35 years.
Get the best of CNBC in your inbox